Examining the data on COVID-19 vaccines for young kids



The news this week that Pfizer is requesting emergency use authorization for its COVID-19 vaccine in children ages 5 to 11 is sparking debate in some families. Some are ready, while others are apprehensive. Professor of economics and public policy at Brown University, Emily Oster, joined CBSN to discuss both sides of the argument.


Source link